The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUAI.L Regulatory News (UAI)

  • There is currently no data for UAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Development & Trading Update

20 Mar 2020 07:00

RNS Number : 8923G
U and I Group PLC
20 March 2020
 

 

This announcement contains inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

 

20 March 2020

 

U and I Group PLC

 

Development & Trading Update

U+I (LSE:UAI), the specialist regeneration developer and investor, today announces an update to its anticipated development and trading gains for FY2020.

Brexit, the related slowdown in decision-making and the only recently resolved political uncertainty in the UK have continued to impact upon timing of some of our projects. In particular this has led to delays in securing planning consents following the election purdah and a further slowdown in transaction timetables. This has recently been dramatically exacerbated by the impact of Covid-19 on the decision-making process, business sentiment and economic activity. The rapidly accelerating impact of the Covid-19 crisis on transactional activity and Central and Local Government policy means that there is currently no reliable way to predict, with certainty, the timing or value of transactions. However, it is now unlikely that sufficient of the projects set out in our guidance at our interim results on 20 November 2019 will contract by 31 March 2020 to enable us to meet the lower end - £35 million - of our gains target for the year. In the normal course of events, we would expect some of the deferred projects to be realised in FY2021 and will provide further detail of these in our full year results.

Based on the projects on which we have certainty, the aggregate amount of our development and trading gains number is currently materially below that £35 million target for the full year. That said, we remain in advanced legal negotiations on several projects within our flexible and substantial development portfolio, including Harwell. If successfully concluded, these could have a material impact on our reported end of year total gains, albeit we expect that amount would still be below the £35 million lower end target. Given the confidential nature of these discussions, the Company is not yet in a position to provide a more detailed review of target gains as it believes this could prejudice its commercial position.

U+I has been actively managing its cost base and in the current climate it will be proactively reducing its operating expenses and all non-essential capital expenditure, with regular discussions to review these key areas and help mitigate risk. It also has the ability to access credit facilities should they be required to manage its liquidity needs, utilising its currently uncharged assets as security.

In addition to RNS releases once transactions close, a post close statement will be issued in early April updating the market on gains, trading and its cost mitigation actions.

Ends

 

 

 

For further information, please contact: 

 

U+I

Nicola Krafft

+44 (0) 20 7828 4777

ir@uandiplc.com

 

Camarco (Financial PR Adviser)

Geoffrey Pelham-Lane / Tom Huddart

+44 (0)20 3757 4985 / 4991

uandi@camarco.co.uk 

 

About U+I

U+I is a specialist regeneration developer and investor.

 

With a >£11.5 billion portfolio of complex, mixed-use, community-focused regeneration projects including a £147.1 million investment portfolio, we are unlocking urban sites bristling with potential in the London City Region (within one hour's commute from Central London), Manchester and Dublin. We exist to create long-term socio-economic benefit for the communities in which we work, delivering sustainable returns to our shareholders.

 

To find out more, visit www.uandiplc.com or follow us @uandiplc  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUKRRRRSUOAUR
Date   Source Headline
10th Mar 20162:50 pmRNSAppointment of Non-Executive Director
9th Mar 201612:20 pmRNSHolding(s) in Company
18th Feb 201610:20 amRNSHolding(s) in Company
16th Feb 201611:08 amRNSHolding(s) in Company
16th Feb 201610:36 amRNSHolding(s) in Company
15th Feb 20164:10 pmRNSHolding(s) in Company
15th Feb 20167:00 amRNSGBP2.3m profit realised from Charlemont sale
12th Feb 201611:22 amRNSHolding(s) in Company
20th Jan 20164:54 pmRNSHolding(s) in Company
12th Jan 20164:55 pmRNSDirector/PDMR Shareholding
11th Jan 201611:23 amRNSDirector/PDMR Shareholding
7th Jan 20162:57 pmRNSDirector/PDMR Shareholding
31st Dec 20157:00 amRNSTotal Voting Rights
22nd Dec 201511:13 amRNSHolding(s) in Company
22nd Dec 201510:37 amRNSDirector/PDMR Shareholding
16th Dec 20157:00 amRNSDisposal in Waterloo generates further profit
15th Dec 201510:31 amRNSBlocklisting Interim Review
9th Dec 20157:00 amRNSPeter Williams appointed as Chairman Designate
7th Dec 20157:00 amRNSProfit realised from Braehead and Watford sales
3rd Dec 20155:04 pmRNSDirector/PDMR Shareholding
3rd Dec 20152:20 pmRNSHolding(s) in Company
3rd Dec 20157:00 amRNSPlanning, funding and pre-sale at Ilford project
1st Dec 201510:41 amRNSHolding(s) in Company
1st Dec 20157:00 amRNSProfit realised from sale in Abbey Wood
18th Nov 20153:23 pmRNSDirector/PDMR Shareholding
18th Nov 20153:22 pmRNSDirector/PDMR Shareholding
18th Nov 20153:19 pmRNSDirector/PDMR Shareholding
16th Nov 201511:32 amRNSDirector/PDMR Shareholding
5th Nov 20155:15 pmRNSChange of Name
3rd Nov 201510:10 amRNSDirector/PDMR Shareholding
22nd Oct 20152:01 pmRNSDirector/PDMR Shareholding
22nd Oct 20151:13 pmRNSDirector/PDMR Shareholding
22nd Oct 20151:12 pmRNSDirector/PDMR Shareholding
21st Oct 20157:00 amRNSInterim Results to 31 August 2015
20th Oct 20155:16 pmRNSProposed Change of Company Name
9th Oct 201511:21 amRNSBlocklisting Interim Review
1st Oct 20158:39 amRNSHolding(s) in Company
16th Sep 20152:46 pmRNSNotice of Interim Results
14th Aug 201512:17 pmRNSDirector/PDMR Shareholding
28th Jul 20159:57 amRNSHolding(s) in Company
22nd Jul 20157:00 amRNSAcquisition of EUR6.0m development site in Dublin
15th Jul 20157:00 amRNSFunding secured for Dublin office building
14th Jul 20153:02 pmRNSResult of AGM
1st Jul 20152:27 pmRNSDirector/PDMR Shareholding
17th Jun 201511:34 amRNSBlocklisting Interim Review
16th Jun 20153:24 pmRNSDirector/PDMR Shareholding
9th Jun 20157:00 amRNSAcquisition of two investment assets in Dublin
8th Jun 20154:53 pmRNSDirector/PDMR Shareholding
22nd May 20154:02 pmRNSAnnual Financial Report
22nd May 201512:29 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.